25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

LFCR (Lifecore) Stock Analysis
Buy, Hold or Sell?

Let's analyze Lifecore together

I guess you are interested in Lifecore Biomedical Inc.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Lifecore’s Financial Insights
  • 📈 Technical Analysis (TA) – Lifecore’s Price Targets

I'm going to help you getting a better view of Lifecore Biomedical Inc.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Lifecore Biomedical Inc.

I send you an email if I find something interesting about Lifecore Biomedical Inc..

1. Quick Overview

1.1. Quick analysis of Lifecore (30 sec.)










1.2. What can you expect buying and holding a share of Lifecore? (30 sec.)

How much money do you get?

How much money do you get?
$0.04
When do you have the money?
1 year
How often do you get paid?
15.0%

What is your share worth?

Current worth
$0.42
Expected worth in 1 year
$0.80
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
$0.42
Return On Investment
6.6%

For what price can you sell your share?

Current Price per Share
$6.41
Expected price per share
$3.6793 - $7.88
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Lifecore (5 min.)




Live pricePrice per Share (EOD)
$6.41
Intrinsic Value Per Share
$-11.84 - $-7.51
Total Value Per Share
$-11.43 - $-7.10

2.2. Growth of Lifecore (5 min.)




Is Lifecore growing?

Current yearPrevious yearGrowGrow %
How rich?$15.4m$29.7m-$2.9m-11.2%

How much money is Lifecore making?

Current yearPrevious yearGrowGrow %
Making money-$16.5m-$12.1m-$4.3m-26.6%
Net Profit Margin-54.8%-32.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Lifecore (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Lifecore?

Welcome investor! Lifecore's management wants to use your money to grow the business. In return you get a share of Lifecore.

First you should know what it really means to hold a share of Lifecore. And how you can make/lose money.

Speculation

The Price per Share of Lifecore is $6.405. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Lifecore.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Lifecore, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.42. Based on the TTM, the Book Value Change Per Share is $0.09 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.49 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Lifecore.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.18-2.8%-0.45-7.0%-0.33-5.2%-0.36-5.7%-0.16-2.5%
Usd Book Value Change Per Share-0.65-10.1%0.091.5%-0.49-7.7%-0.33-5.1%-0.13-2.1%
Usd Dividend Per Share0.000.0%0.010.2%0.030.5%0.010.1%0.060.9%
Usd Total Gains Per Share-0.65-10.1%0.111.6%-0.46-7.1%-0.32-5.0%-0.07-1.2%
Usd Price Per Share7.41-6.50-7.29-8.93-10.88-
Price to Earnings Ratio-10.44--5.68--2.10--8.10-35.71-
Price-to-Total Gains Ratio-11.41--28.56-3.61--35.27-235.61-
Price to Book Ratio17.76--35.49-44.01-3.16-2.59-
Price-to-Total Gains Ratio-11.41--28.56-3.61--35.27-235.61-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share6.405
Number of shares156
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.09-0.33
Usd Total Gains Per Share0.11-0.32
Gains per Quarter (156 shares)16.41-49.96
Gains per Year (156 shares)65.65-199.84
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1759565-205-210
21311812211-411-410
32017718816-616-610
42623625422-821-810
53329632027-1026-1010
63935538633-1232-1210
74641445238-1437-1410
85247351844-1642-1610
95953258449-1848-1810
106559165055-2053-2010

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%1.019.00.05.0%17.023.00.042.5%62.053.00.053.9%
Book Value Change Per Share1.03.00.025.0%3.08.01.025.0%3.016.01.015.0%20.019.01.050.0%68.046.01.059.1%
Dividend per Share2.00.02.050.0%4.00.08.033.3%4.00.016.020.0%6.00.034.015.0%14.00.0101.012.2%
Total Gains per Share1.03.00.025.0%3.08.01.025.0%3.016.01.015.0%20.019.01.050.0%68.046.01.059.1%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Lifecore Biomedical Inc. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.6500.095-786%-0.491-24%-0.329-49%-0.132-80%
Book Value Per Share--0.4170.723-42%0.803-48%3.142-87%4.766-91%
Current Ratio--2.3202.199+6%1.999+16%1.558+49%1.476+57%
Debt To Asset Ratio--0.9400.897+5%0.891+5%0.719+31%0.556+69%
Debt To Equity Ratio--15.5314.902+217%44.960-65%10.908+42%5.788+168%
Dividend Per Share---0.010-100%0.033-100%0.009-100%0.058-100%
Enterprise Value--43875473.00020098823.500+118%48009373.750-9%89435403.700-51%205310026.050-79%
Eps---0.177-0.446+151%-0.332+87%-0.363+104%-0.162-9%
Ev To Ebitda Ratio--22.4314.238+429%infnan%infnan%infnan%
Ev To Sales Ratio--0.3370.133+153%0.413-18%0.371-9%0.486-31%
Free Cash Flow Per Share---0.232-0.218-6%-0.302+30%-0.202-13%-0.152-34%
Free Cash Flow To Equity Per Share--0.1060.010+915%-0.128+221%-0.236+322%-0.080+175%
Gross Profit Margin--1.0001.0000%1.0010%1.008-1%1.115-10%
Intrinsic Value_10Y_max---7.514--------
Intrinsic Value_10Y_min---11.845--------
Intrinsic Value_1Y_max---0.630--------
Intrinsic Value_1Y_min---1.165--------
Intrinsic Value_3Y_max---1.986--------
Intrinsic Value_3Y_min---3.541--------
Intrinsic Value_5Y_max---3.456--------
Intrinsic Value_5Y_min---5.941--------
Market Cap237147046.500-16%274357473.000240479323.500+14%269821873.750+2%330598903.700-17%402779726.050-32%
Net Profit Margin---0.202-0.548+171%-0.323+60%-0.306+52%-0.148-26%
Operating Margin---0.048-0.146+206%-0.094+98%-0.135+183%-0.062+30%
Operating Ratio--1.0601.156-8%1.584-33%1.215-13%1.097-3%
Pb Ratio15.350-16%17.759-35.491+300%44.013-60%3.155+463%2.589+586%
Pe Ratio-9.022+14%-10.438-5.677-46%-2.102-80%-8.100-22%35.714-129%
Price Per Share6.405-16%7.4106.495+14%7.288+2%8.929-17%10.879-32%
Price To Free Cash Flow Ratio-6.910+14%-7.994-3.056-62%-9.373+17%-5.116-36%-2.631-67%
Price To Total Gains Ratio-9.859+14%-11.406-28.564+150%3.612-416%-35.271+209%235.607-105%
Quick Ratio--0.8400.968-13%0.746+13%0.652+29%0.752+12%
Return On Assets---0.026-0.065+152%-0.045+74%-0.046+79%-0.021-18%
Return On Equity---0.425-0.139-67%2.294-119%0.366-216%0.186-329%
Total Gains Per Share---0.6500.105-717%-0.458-30%-0.320-51%-0.074-89%
Usd Book Value--15449000.00026753000.000-42%29741750.000-48%116319550.000-87%176455025.000-91%
Usd Book Value Change Per Share---0.6500.095-786%-0.491-24%-0.329-49%-0.132-80%
Usd Book Value Per Share--0.4170.723-42%0.803-48%3.142-87%4.766-91%
Usd Dividend Per Share---0.010-100%0.033-100%0.009-100%0.058-100%
Usd Enterprise Value--43875473.00020098823.500+118%48009373.750-9%89435403.700-51%205310026.050-79%
Usd Eps---0.177-0.446+151%-0.332+87%-0.363+104%-0.162-9%
Usd Free Cash Flow---8580000.000-8055250.000-6%-11185000.250+30%-7494150.050-13%-5627525.025-34%
Usd Free Cash Flow Per Share---0.232-0.218-6%-0.302+30%-0.202-13%-0.152-34%
Usd Free Cash Flow To Equity Per Share--0.1060.010+915%-0.128+221%-0.236+322%-0.080+175%
Usd Market Cap237147046.500-16%274357473.000240479323.500+14%269821873.750+2%330598903.700-17%402779726.050-32%
Usd Price Per Share6.405-16%7.4106.495+14%7.288+2%8.929-17%10.879-32%
Usd Profit---6571000.000-16503500.000+151%-12117000.000+84%-14454700.000+120%-6525050.000-1%
Usd Revenue--32564000.00031675250.000+3%32474750.000+0%77963350.000-58%106734700.000-69%
Usd Total Gains Per Share---0.6500.105-717%-0.458-30%-0.320-51%-0.074-89%
 EOD+3 -5MRQTTM+21 -19YOY+21 -185Y+15 -2410Y+9 -30

3.3 Fundamental Score

Let's check the fundamental score of Lifecore Biomedical Inc. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-9.022
Price to Book Ratio (EOD)Between0-115.350
Net Profit Margin (MRQ)Greater than0-0.202
Operating Margin (MRQ)Greater than0-0.048
Quick Ratio (MRQ)Greater than10.840
Current Ratio (MRQ)Greater than12.320
Debt to Asset Ratio (MRQ)Less than10.940
Debt to Equity Ratio (MRQ)Less than115.531
Return on Equity (MRQ)Greater than0.15-0.425
Return on Assets (MRQ)Greater than0.05-0.026
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Lifecore Biomedical Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.798
Ma 20Greater thanMa 506.327
Ma 50Greater thanMa 1006.161
Ma 100Greater thanMa 2006.517
OpenGreater thanClose6.330
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Lifecore Biomedical Inc.

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

Fundamental data was last updated by Penke on 2025-04-05 08:39:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Lifecore earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Lifecore to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -20.2% means that $-0.20 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Lifecore Biomedical Inc.:

  • The MRQ is -20.2%. The company is making a huge loss. -2
  • The TTM is -54.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-20.2%TTM-54.8%+34.6%
TTM-54.8%YOY-32.3%-22.5%
TTM-54.8%5Y-30.6%-24.1%
5Y-30.6%10Y-14.8%-15.8%
4.3.1.2. Return on Assets

Shows how efficient Lifecore is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Lifecore to the Drug Manufacturers - Specialty & Generic industry mean.
  • -2.6% Return on Assets means that Lifecore generated $-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Lifecore Biomedical Inc.:

  • The MRQ is -2.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -6.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.6%TTM-6.5%+3.9%
TTM-6.5%YOY-4.5%-2.0%
TTM-6.5%5Y-4.6%-1.9%
5Y-4.6%10Y-2.1%-2.5%
4.3.1.3. Return on Equity

Shows how efficient Lifecore is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Lifecore to the Drug Manufacturers - Specialty & Generic industry mean.
  • -42.5% Return on Equity means Lifecore generated $-0.43 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Lifecore Biomedical Inc.:

  • The MRQ is -42.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -13.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-42.5%TTM-13.9%-28.6%
TTM-13.9%YOY229.4%-243.4%
TTM-13.9%5Y36.6%-50.5%
5Y36.6%10Y18.6%+18.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Lifecore Biomedical Inc..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Lifecore is operating .

  • Measures how much profit Lifecore makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Lifecore to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -4.8% means the company generated $-0.05  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Lifecore Biomedical Inc.:

  • The MRQ is -4.8%. The company is operating very inefficient. -2
  • The TTM is -14.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-4.8%TTM-14.6%+9.8%
TTM-14.6%YOY-9.4%-5.2%
TTM-14.6%5Y-13.5%-1.1%
5Y-13.5%10Y-6.2%-7.3%
4.3.2.2. Operating Ratio

Measures how efficient Lifecore is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.06 means that the operating costs are $1.06 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Lifecore Biomedical Inc.:

  • The MRQ is 1.060. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.156. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.060TTM1.156-0.096
TTM1.156YOY1.584-0.428
TTM1.1565Y1.215-0.059
5Y1.21510Y1.097+0.118
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Lifecore Biomedical Inc..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Lifecore is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.32 means the company has $2.32 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Lifecore Biomedical Inc.:

  • The MRQ is 2.320. The company is able to pay all its short-term debts. +1
  • The TTM is 2.199. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.320TTM2.199+0.121
TTM2.199YOY1.999+0.200
TTM2.1995Y1.558+0.640
5Y1.55810Y1.476+0.082
4.4.3.2. Quick Ratio

Measures if Lifecore is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Lifecore to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.84 means the company can pay off $0.84 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Lifecore Biomedical Inc.:

  • The MRQ is 0.840. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.968. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.840TTM0.968-0.129
TTM0.968YOY0.746+0.223
TTM0.9685Y0.652+0.316
5Y0.65210Y0.752-0.100
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Lifecore Biomedical Inc..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Lifecore assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Lifecore to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.94 means that Lifecore assets are financed with 94.0% credit (debt) and the remaining percentage (100% - 94.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Lifecore Biomedical Inc.:

  • The MRQ is 0.940. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.897. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.940TTM0.897+0.042
TTM0.897YOY0.891+0.006
TTM0.8975Y0.719+0.179
5Y0.71910Y0.556+0.162
4.5.4.2. Debt to Equity Ratio

Measures if Lifecore is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Lifecore to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 1,553.1% means that company has $15.53 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Lifecore Biomedical Inc.:

  • The MRQ is 15.531. The company is unable to pay all its debts with equity. -1
  • The TTM is 4.902. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ15.531TTM4.902+10.629
TTM4.902YOY44.960-40.058
TTM4.9025Y10.908-6.006
5Y10.90810Y5.788+5.120
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Lifecore generates.

  • Above 15 is considered overpriced but always compare Lifecore to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -10.44 means the investor is paying $-10.44 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Lifecore Biomedical Inc.:

  • The EOD is -9.022. Based on the earnings, the company is expensive. -2
  • The MRQ is -10.438. Based on the earnings, the company is expensive. -2
  • The TTM is -5.677. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.022MRQ-10.438+1.416
MRQ-10.438TTM-5.677-4.761
TTM-5.677YOY-2.102-3.575
TTM-5.6775Y-8.100+2.423
5Y-8.10010Y35.714-43.814
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Lifecore Biomedical Inc.:

  • The EOD is -6.910. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -7.994. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.056. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.910MRQ-7.994+1.084
MRQ-7.994TTM-3.056-4.938
TTM-3.056YOY-9.373+6.317
TTM-3.0565Y-5.116+2.061
5Y-5.11610Y-2.631-2.486
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Lifecore is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Lifecore Biomedical Inc.:

  • The EOD is 15.350. Based on the equity, the company is expensive. -2
  • The MRQ is 17.759. Based on the equity, the company is expensive. -2
  • The TTM is -35.491. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD15.350MRQ17.759-2.409
MRQ17.759TTM-35.491+53.250
TTM-35.491YOY44.013-79.504
TTM-35.4915Y3.155-38.646
5Y3.15510Y2.589+0.566
4.6.2. Total Gains per Share

2.4. Latest News of Lifecore Biomedical Inc.

Does Lifecore Biomedical Inc. still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Lifecore Biomedical Inc. to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-04-16
22:05
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Read

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Lifecore Biomedical Inc..

4.8.1. Institutions holding Lifecore Biomedical Inc.

Institutions are holding 73.489% of the shares of Lifecore Biomedical Inc..

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-12-31Wynnefield Capital Inc12.702715.92524703216-215763-4.3863
2024-12-31Legion Partners Asset Management, LLC11.969719.2054431823146341449.2996
2024-12-31Greenhaven Road Investment Management, L.P.9.76674.29763616146138736262.2475
2024-12-31325 Capital LLC5.84056.2111216246679268157.869
2024-12-3122NW, LP4.740419.6475175516100
2024-12-31BlackRock Inc4.36590.000216164811035356.8433
2024-12-31Vanguard Group Inc4.13410.0002153065321543716.3804
2024-12-31Morgan Stanley - Brokerage Accounts2.01260.0004745185-31505-4.0563
2024-12-31Geode Capital Management, LLC1.85210.00046857468806114.7337
2024-12-31Amvescap Plc.1.50060.00085556075556070
2024-12-31DCF Advisers, LLC1.45841.941353998925151187.1855
2024-12-31State Street Corp1.01360.00013752804092012.2383
2024-12-31Northern Trust Corp0.59820.00022214982801914.4817
2024-12-31Tocqueville Asset Management L.P.0.40970.017715170000
2024-12-31Marshall Wace Asset Management Ltd0.35970.0012133191-67509-33.6368
2024-12-31Quinn Opportunity Partners LLC0.34540.064112790400
2024-12-31Alpha Wave Global LP0.31480.39731165381165380
2024-12-31UBS Group AG0.29430.000210898172890201.9617
2024-12-31BOOTHBAY FUND MANAGEMENT, LLC0.23540.01687142-100004-53.4364
2024-12-31Gamco Investors, Inc. Et Al0.23230.006786000-1500-1.7143
Total 64.147167.733223750707+4699694+19.8%

4.9.2. Funds holding Lifecore Biomedical Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-02-28Vanguard Total Stock Mkt Idx Inv2.05070.000375929300
2025-02-28Vanguard Institutional Extnd Mkt Idx Tr1.59690.003159126600
2025-02-28iShares Russell 2000 ETF1.41770.0046524904-6205-1.1683
2025-02-28Invesco Dorsey Wright SmallCap Momt ETF1.16240.3415430395-996-0.2309
2024-12-31Fidelity Small Cap Index0.61270.006222684000
2025-02-28iShares Russell 2000 Value ETF0.55950.0104207167-1573-0.7536
2025-01-31Fidelity Extended Market Index0.54180.0028200597-3047-1.4962
2025-02-28Vanguard Russell 2000 ETF0.27880.00510321124132.3939
2025-02-28State St Russell Sm Cap® Indx SL Cl I0.2450.005990710-10990-10.8063
2024-12-31Delafield Concentrated Value0.24313.39219000000
2025-01-311290 VT GAMCO Small Company Value IB0.21610.01298000000
2024-12-31Bridgeway Ultra-Small Company Market0.20770.31667690000
2024-12-31Extended Equity Market Fund K0.19570.0036724502152542.268
2025-01-31Fidelity Total Market Index0.19110.000470767678710.608
2025-02-28Schwab Small Cap Index0.15120.00525600000
2024-12-31NT R2000 Value Index Fund - NL0.15050.0135571600
2024-12-31NT R2000 Index Fund - NL0.14890.006455117440.0799
2025-02-28iShares Micro-Cap ETF0.1380.03375110200
2025-01-31Fidelity Series Total Market Index0.13250.000449041-1878-3.6882
2024-12-31NT R2000 Value Index Fund - L0.12350.01284572115153.4271
Total 10.36384.17693837197+7595+0.2%

5.3. Insider Transactions

Insiders are holding 0.868% of the shares of Lifecore Biomedical Inc..

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-01-08Paul JosephsBUY170005.74
2024-10-03Wynnefield Partners Small CapBUY1229304.1
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-11-30. Currency in USD. All numbers in thousands.

Summary
Total Assets255,386
Total Liabilities239,937
Total Stockholder Equity15,449
 As reported
Total Liabilities 239,937
Total Stockholder Equity+ 15,449
Total Assets = 255,386

Assets

Total Assets255,386
Total Current Assets81,858
Long-term Assets173,528
Total Current Assets
Cash And Cash Equivalents 9,455
Net Receivables 20,177
Inventory 39,214
Other Current Assets 13,012
Total Current Assets  (as reported)81,858
Total Current Assets  (calculated)81,858
+/-0
Long-term Assets
Property Plant Equipment 152,880
Goodwill 13,881
Intangible Assets 4,200
Long-term Assets Other 2,567
Long-term Assets  (as reported)173,528
Long-term Assets  (calculated)173,528
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities35,290
Long-term Liabilities160,336
Total Stockholder Equity15,449
Total Current Liabilities
Short-term Debt 4,889
Short Long Term Debt 773
Accounts payable 14,967
Other Current Liabilities 14,497
Total Current Liabilities  (as reported)35,290
Total Current Liabilities  (calculated)35,126
+/- 164
Long-term Liabilities
Long term Debt 119,028
Capital Lease Obligations 11,539
Long-term Liabilities Other 5,153
Long-term Liabilities  (as reported)160,336
Long-term Liabilities  (calculated)135,720
+/- 24,616
Total Stockholder Equity
Common Stock37
Retained Earnings -191,456
Other Stockholders Equity 162,557
Total Stockholder Equity (as reported)15,449
Total Stockholder Equity (calculated)-28,862
+/- 44,311
Other
Capital Stock37
Cash and Short Term Investments 9,455
Common Stock Shares Outstanding 34,361
Current Deferred Revenue937
Liabilities and Stockholders Equity 255,386
Net Debt 121,885
Net Invested Capital 135,250
Net Working Capital 46,568
Property Plant and Equipment Gross 207,251
Short Long Term Debt Total 131,340



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-11-302024-08-312024-05-312024-02-292023-11-302023-08-312023-05-312023-02-282022-11-302022-08-312022-05-312022-02-282021-11-302021-08-312021-05-312021-02-282020-11-302020-08-312020-05-312020-02-292019-11-302019-08-312019-05-312019-02-282018-11-302018-08-312018-05-312018-02-282017-11-302017-08-312017-05-312017-02-282016-11-302016-08-312016-05-312016-02-292015-11-302015-08-312015-05-312015-02-282014-11-302014-08-312014-05-312014-02-282013-11-302013-08-312013-05-312013-02-282012-11-302012-08-312012-05-312012-02-292011-11-302011-08-312011-05-312011-02-282010-11-302010-08-312010-05-312010-02-282009-11-302009-08-312009-05-312009-02-282008-11-302008-08-312008-05-312008-02-292007-11-302007-08-312007-05-312007-02-282006-11-302006-08-312006-05-312006-02-282005-11-302005-08-312005-05-312005-02-282004-11-302004-08-312004-05-312004-02-292003-11-302003-08-312003-05-312003-02-282002-11-302002-08-312002-05-312002-02-282001-11-302001-08-312001-05-312001-02-282000-11-302000-08-312000-05-312000-02-291999-11-301999-08-311999-05-311999-02-281998-11-301998-08-311998-05-311998-02-281997-11-301997-08-311997-05-311997-02-281996-11-301996-08-311996-05-311996-02-291995-11-30
> Total Assets 
0
41,100
39,700
38,400
37,000
45,800
44,100
50,200
44,700
40,500
38,500
42,400
46,000
42,700
40,400
40,700
120,300
123,731
131,145
133,252
129,622
126,223
125,681
120,122
122,633
116,063
112,358
107,803
103,654
97,173
95,955
90,965
96,173
95,955
93,007
93,601
99,508
101,032
100,075
98,956
109,942
119,022
119,025
114,281
125,918
135,691
141,368
127,065
127,978
133,238
150,589
152,789
150,926
148,222
153,498
163,662
160,395
159,572
200,197
205,729
207,028
208,677
206,312
208,891
209,408
211,546
277,692
267,960
278,112
282,995
290,942
290,833
302,256
306,781
313,623
325,938
341,099
340,303
346,465
342,585
361,105
328,677
343,470
343,772
341,341
346,136
358,008
366,967
379,308
385,836
404,703
402,901
411,654
501,583
519,091
546,137
559,997
550,060
541,313
506,180
499,160
509,823
502,924
445,619
422,124
325,582
295,160
295,160
279,073
285,800
236,153
245,620
245,816
255,150
273,702
246,824
255,386
255,386246,824273,702255,150245,816245,620236,153285,800279,073295,160295,160325,582422,124445,619502,924509,823499,160506,180541,313550,060559,997546,137519,091501,583411,654402,901404,703385,836379,308366,967358,008346,136341,341343,772343,470328,677361,105342,585346,465340,303341,099325,938313,623306,781302,256290,833290,942282,995278,112267,960277,692211,546209,408208,891206,312208,677207,028205,729200,197159,572160,395163,662153,498148,222150,926152,789150,589133,238127,978127,065141,368135,691125,918114,281119,025119,022109,94298,956100,075101,03299,50893,60193,00795,95596,17390,96595,95597,173103,654107,803112,358116,063122,633120,122125,681126,223129,622133,252131,145123,731120,30040,70040,40042,70046,00042,40038,50040,50044,70050,20044,10045,80037,00038,40039,70041,1000
   > Total Current Assets 
0
40,000
38,400
37,300
35,600
34,700
32,900
30,000
24,600
19,800
16,700
19,800
23,200
19,200
16,600
16,200
52,700
55,952
63,413
63,078
58,816
55,479
52,805
59,940
62,465
55,267
51,245
46,485
45,226
39,161
38,226
33,553
38,449
38,226
36,011
36,632
42,133
43,798
44,377
43,559
48,925
56,695
54,702
48,188
74,454
83,472
89,139
74,016
74,317
79,245
90,666
92,589
89,819
86,758
91,334
100,716
96,214
95,455
88,942
93,918
94,548
80,841
85,626
87,989
87,177
86,108
81,163
70,141
77,236
81,987
85,660
77,725
85,540
88,929
90,929
89,250
94,944
92,491
93,202
87,346
95,194
83,905
86,478
87,773
84,475
86,575
81,280
88,520
95,987
94,451
97,063
88,317
92,466
114,333
133,041
130,562
140,180
148,811
157,107
147,367
154,187
162,927
148,321
142,409
154,521
132,037
123,712
123,712
127,092
116,598
88,439
82,814
76,714
99,261
81,033
74,183
81,858
81,85874,18381,03399,26176,71482,81488,439116,598127,092123,712123,712132,037154,521142,409148,321162,927154,187147,367157,107148,811140,180130,562133,041114,33392,46688,31797,06394,45195,98788,52081,28086,57584,47587,77386,47883,90595,19487,34693,20292,49194,94489,25090,92988,92985,54077,72585,66081,98777,23670,14181,16386,10887,17787,98985,62680,84194,54893,91888,94295,45596,214100,71691,33486,75889,81992,58990,66679,24574,31774,01689,13983,47274,45448,18854,70256,69548,92543,55944,37743,79842,13336,63236,01138,22638,44933,55338,22639,16145,22646,48551,24555,26762,46559,94052,80555,47958,81663,07863,41355,95252,70016,20016,60019,20023,20019,80016,70019,80024,60030,00032,90034,70035,60037,30038,40040,0000
       Cash And Cash Equivalents 
0
20,200
13,600
14,200
10,400
2,000
7,700
5,200
11,500
10,900
6,000
9,200
9,000
7,500
4,300
3,200
8,400
6,453
10,878
9,589
6,508
5,937
5,456
8,695
7,601
8,599
1,219
7,849
5,339
3,562
6,248
4,370
2,296
6,248
6,458
5,585
6,215
14,899
12,871
8,423
6,451
20,095
20,519
14,363
11,751
58,298
62,556
46,250
45,130
55,265
44,396
45,747
42,345
47,276
43,459
3,998
2,222
6,339
27,817
9,898
5,447
6,679
8,135
7,242
4,235
12,534
22,177
10,049
4,856
9,943
13,718
8,897
5,766
12,987
14,243
8,529
4,970
15,695
14,127
7,103
5,975
8,214
9,894
8,626
2,566
12,734
5,409
8,191
4,369
7,650
2,899
1,359
1,514
1,722
1,080
1,990
1,594
2,607
360
589
2,491
2,248
1,295
1,447
1,091
1,854
1,643
1,643
6,830
4,222
2,950
8,642
3,221
19,091
8,462
5,520
9,455
9,4555,5208,46219,0913,2218,6422,9504,2226,8301,6431,6431,8541,0911,4471,2952,2482,4915893602,6071,5941,9901,0801,7221,5141,3592,8997,6504,3698,1915,40912,7342,5668,6269,8948,2145,9757,10314,12715,6954,9708,52914,24312,9875,7668,89713,7189,9434,85610,04922,17712,5344,2357,2428,1356,6795,4479,89827,8176,3392,2223,99843,45947,27642,34545,74744,39655,26545,13046,25062,55658,29811,75114,36320,51920,0956,4518,42312,87114,8996,2155,5856,4586,2482,2964,3706,2483,5625,3397,8491,2198,5997,6018,6955,4565,9376,5089,58910,8786,4538,4003,2004,3007,5009,0009,2006,00010,90011,5005,2007,7002,00010,40014,20013,60020,2000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,968
2,986
2,986
0
0
0
0
0
0
0
0
0
14,643
16,256
18,882
16,640
22,498
65,460
65,851
63,282
20,421
40,736
39,593
31,756
28,124
32,112
24,236
25,094
3,790
756
1,959
3,790
1,545
1,297
1,297
0
-9,507
0
9,507
0
-200
0
200
0
-700
0
700
681
-1,300
0
1,300
1,467
-600
0
600
992
-200
0
200
58
11,800
0
-11,800
0
0
0
0
0
0
0
0
86
0
0
0
0
0
0
0
00000008600000000-11,800011,800582000-2009926000-6001,4671,3000-1,3006817000-70002000-20009,5070-9,50701,2971,2971,5453,7901,9597563,79025,09424,23632,11228,12431,75639,59340,73620,42163,28265,85165,46022,49816,64018,88216,25614,6430000000002,9862,9861,96800000000000000000000000000000000000000
       Net Receivables 
0
100
100
0
100
2,000
2,300
2,200
2,100
2,400
2,200
2,800
2,800
2,600
2,800
3,000
24,100
22,252
34,202
22,725
26,109
26,526
25,663
18,554
21,096
19,606
25,348
23,436
17,442
18,441
11,700
12,292
13,120
11,700
16,799
16,403
16,925
12,521
16,389
18,134
19,989
13,825
18,588
16,002
18,291
17,710
18,467
18,408
19,641
15,952
20,372
19,420
17,226
13,326
16,089
19,750
18,264
15,033
20,346
21,623
26,942
20,003
22,677
21,290
29,764
23,956
32,321
30,879
40,929
37,579
41,846
38,120
46,892
45,444
46,725
44,816
52,454
46,521
46,631
44,654
50,283
42,924
46,406
44,150
50,009
45,918
47,083
47,851
56,356
50,438
53,877
48,660
53,420
60,390
69,565
61,402
69,962
69,763
76,206
65,027
66,545
69,577
70,013
61,956
65,276
49,559
48,172
48,172
35,689
40,934
32,371
26,617
30,202
29,708
31,153
25,145
20,177
20,17725,14531,15329,70830,20226,61732,37140,93435,68948,17248,17249,55965,27661,95670,01369,57766,54565,02776,20669,76369,96261,40269,56560,39053,42048,66053,87750,43856,35647,85147,08345,91850,00944,15046,40642,92450,28344,65446,63146,52152,45444,81646,72545,44446,89238,12041,84637,57940,92930,87932,32123,95629,76421,29022,67720,00326,94221,62320,34615,03318,26419,75016,08913,32617,22619,42020,37215,95219,64118,40818,46717,71018,29116,00218,58813,82519,98918,13416,38912,52116,92516,40316,79911,70013,12012,29211,70018,44117,44223,43625,34819,60621,09618,55425,66326,52626,10922,72534,20222,25224,1003,0002,8002,6002,8002,8002,2002,4002,1002,2002,3002,00010001001000
       Other Current Assets 
0
19,200
24,100
22,600
24,600
28,400
20,800
19,900
7,700
3,300
4,000
3,100
2,600
1,900
1,900
2,400
3,100
12,803
3,084
16,263
7,235
3,302
3,205
15,273
14,730
13,849
11,803
1,591
700
411
1,423
78
2,270
1,423
1,527
1,471
1,737
1,971
1,190
1,190
1,190
1,876
1,637
1,826
35,048
1,645
1,316
1,558
1,126
1,714
3,926
2,985
3,701
4,222
3,459
69,458
68,073
69,621
4,251
50,634
45,040
38,435
6,529
39,354
28,471
37,628
2,578
4,914
5,090
8,290
2,856
2,816
4,217
3,059
3,170
5,993
5,095
3,626
5,306
5,128
8,012
5,606
4,643
4,815
3,930
4,650
3,498
4,339
4,426
7,614
7,958
8,312
5,904
7,994
8,264
12,150
10,061
9,382
14,230
21,753
13,949
14,323
7,350
9,591
8,721
6,924
7,052
7,052
700
7,157
4,422
5,865
1,845
5,078
1,439
1,876
13,012
13,0121,8761,4395,0781,8455,8654,4227,1577007,0527,0526,9248,7219,5917,35014,32313,94921,75314,2309,38210,06112,1508,2647,9945,9048,3127,9587,6144,4264,3393,4984,6503,9304,8154,6435,6068,0125,1285,3063,6265,0955,9933,1703,0594,2172,8162,8568,2905,0904,9142,57837,62828,47139,3546,52938,43545,04050,6344,25169,62168,07369,4583,4594,2223,7012,9853,9261,7141,1261,5581,3161,64535,0481,8261,6371,8761,1901,1901,1901,9711,7371,4711,5271,4232,270781,4234117001,59111,80313,84914,73015,2733,2053,3027,23516,2633,08412,8033,1002,4001,9001,9002,6003,1004,0003,3007,70019,90020,80028,40024,60022,60024,10019,2000
   > Long-term Assets 
0
1,100
1,300
1,100
1,400
11,100
11,200
20,200
20,100
20,700
21,800
22,600
22,800
23,500
23,800
24,500
67,600
67,779
67,732
70,174
70,806
70,744
72,876
60,182
60,168
60,796
61,113
61,318
58,428
58,012
57,729
57,412
57,724
57,729
56,996
56,969
57,375
57,234
55,698
55,397
61,017
62,327
64,323
66,093
51,464
52,219
52,229
53,049
53,661
53,993
59,923
60,200
61,107
61,464
62,164
62,946
64,181
64,117
111,255
111,811
112,480
127,836
120,686
120,902
122,231
125,438
196,529
197,819
200,876
201,008
205,282
213,108
216,716
217,852
222,694
236,688
246,155
247,812
253,263
255,239
265,911
244,772
256,992
255,999
256,866
259,561
276,728
278,447
283,321
291,385
307,640
314,584
319,188
387,250
386,050
415,575
419,817
401,249
384,206
358,813
344,973
346,896
354,603
303,210
267,603
193,545
171,448
171,448
151,981
169,202
147,714
162,806
169,102
155,889
192,669
172,641
173,528
173,528172,641192,669155,889169,102162,806147,714169,202151,981171,448171,448193,545267,603303,210354,603346,896344,973358,813384,206401,249419,817415,575386,050387,250319,188314,584307,640291,385283,321278,447276,728259,561256,866255,999256,992244,772265,911255,239253,263247,812246,155236,688222,694217,852216,716213,108205,282201,008200,876197,819196,529125,438122,231120,902120,686127,836112,480111,811111,25564,11764,18162,94662,16461,46461,10760,20059,92353,99353,66153,04952,22952,21951,46466,09364,32362,32761,01755,39755,69857,23457,37556,96956,99657,72957,72457,41257,72958,01258,42861,31861,11360,79660,16860,18272,87670,74470,80670,17467,73267,77967,60024,50023,80023,50022,80022,60021,80020,70020,10020,20011,20011,1001,4001,1001,3001,1000
       Property Plant Equipment 
0
1,000
900
1,000
1,200
3,900
4,100
5,000
5,200
5,800
7,200
8,300
8,800
9,400
10,000
11,000
26,500
25,842
26,485
24,437
25,998
27,021
28,730
19,999
20,523
20,017
20,325
19,902
19,202
18,689
18,636
18,229
18,440
18,636
18,341
18,396
18,771
18,537
17,275
17,137
17,504
17,500
19,014
20,504
19,625
20,164
20,270
19,790
20,259
20,361
21,306
21,384
22,083
22,116
22,743
23,325
24,361
24,097
50,161
50,573
51,130
51,323
51,779
52,063
52,247
51,791
63,495
63,776
63,443
63,056
65,811
68,489
70,024
70,973
74,140
76,946
78,375
78,960
84,465
85,954
95,869
108,719
120,880
120,720
120,972
123,005
133,220
132,637
135,271
143,362
159,624
165,875
170,517
191,892
200,027
230,283
234,466
216,969
217,659
193,522
192,043
192,221
200,386
194,759
191,908
132,005
139,015
139,015
126,803
137,253
126,723
140,418
146,949
134,593
151,040
151,129
152,880
152,880151,129151,040134,593146,949140,418126,723137,253126,803139,015139,015132,005191,908194,759200,386192,221192,043193,522217,659216,969234,466230,283200,027191,892170,517165,875159,624143,362135,271132,637133,220123,005120,972120,720120,880108,71995,86985,95484,46578,96078,37576,94674,14070,97370,02468,48965,81163,05663,44363,77663,49551,79152,24752,06351,77951,32351,13050,57350,16124,09724,36123,32522,74322,11622,08321,38421,30620,36120,25919,79020,27020,16419,62520,50419,01417,50017,50417,13717,27518,53718,77118,39618,34118,63618,44018,22918,63618,68919,20219,90220,32520,01720,52319,99928,73027,02125,99824,43726,48525,84226,50011,00010,0009,4008,8008,3007,2005,8005,2005,0004,1003,9001,2001,0009001,0000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
29,124
29,507
21,248
21,401
21,402
22,506
22,535
22,566
27,354
27,354
27,361
27,361
27,361
27,361
27,361
27,361
41,154
41,189
41,189
41,243
36,462
36,462
36,462
36,462
49,620
49,620
49,620
49,620
49,620
49,620
49,620
49,620
49,620
49,620
49,620
49,620
49,620
49,620
49,620
49,620
49,620
49,620
49,620
49,620
54,779
54,779
54,779
54,779
54,510
54,510
54,510
75,739
76,742
76,742
77,246
77,246
69,386
69,386
69,386
69,386
69,386
69,386
37,329
33,916
13,881
13,881
13,881
13,881
13,881
13,881
13,881
13,881
13,881
13,881
13,881
13,88113,88113,88113,88113,88113,88113,88113,88113,88113,88113,88133,91637,32969,38669,38669,38669,38669,38669,38677,24677,24676,74276,74275,73954,51054,51054,51054,77954,77954,77954,77949,62049,62049,62049,62049,62049,62049,62049,62049,62049,62049,62049,62049,62049,62049,62049,62049,62049,62049,62049,62036,46236,46236,46236,46241,24341,18941,18941,15427,36127,36127,36127,36127,36127,36127,35427,35422,56622,53522,50621,40221,40121,24829,50729,124000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
7,100
6,900
15,000
14,700
14,800
14,500
14,300
14,000
14,100
13,800
13,500
38,400
40,207
39,541
43,386
42,588
42,148
41,964
37,105
37,079
37,517
37,502
37,480
37,465
37,838
37,667
37,725
37,691
37,667
37,642
37,628
37,891
37,615
37,615
37,615
43,010
43,137
14,130
14,092
8,228
8,228
8,228
8,228
8,228
8,228
8,228
8,228
8,228
8,228
8,228
35,589
35,589
35,589
12,428
57,214
57,136
57,113
15,794
52,179
52,102
52,025
58,985
58,697
58,476
58,255
58,034
57,812
57,591
57,370
57,148
56,927
56,705
56,484
56,263
56,060
55,839
21,617
21,396
21,175
20,953
20,732
22,811
22,590
22,319
22,080
21,842
21,604
21,366
47,749
45,247
44,735
44,222
43,710
38,105
37,609
37,112
36,616
36,120
35,623
35,127
24,576
15,550
15,550
8,692
15,275
4,400
4,200
4,200
4,200
4,200
4,200
4,200
4,2004,2004,2004,2004,2004,2004,40015,2758,69215,55015,55024,57635,12735,62336,12036,61637,11237,60938,10543,71044,22244,73545,24747,74921,36621,60421,84222,08022,31922,59022,81120,73220,95321,17521,39621,61755,83956,06056,26356,48456,70556,92757,14857,37057,59157,81258,03458,25558,47658,69758,98552,02552,10252,17915,79457,11357,13657,21412,42835,58935,58935,5898,2288,2288,2288,2288,2288,2288,2288,2288,2288,2288,22814,09214,13043,13743,01037,61537,61537,61537,89137,62837,64237,66737,69137,72537,66737,83837,46537,48037,50237,51737,07937,10541,96442,14842,58843,38639,54140,20738,40013,50013,80014,10014,00014,30014,50014,80014,70015,0006,9007,10000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,239
3,048
3,002
2,793
2,605
0
3,215
0
0
0
0
0
0
0000003,21502,6052,7933,0023,0483,23900000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
2,000
1,500
1,800
1,600
12,800
12,000
14,600
10,600
3,700
2,800
8,700
13,400
6,700
6,200
8,900
68,400
66,734
74,647
79,810
80,218
73,405
73,900
69,248
75,058
55,648
52,042
50,260
48,422
37,569
37,769
32,356
39,022
37,769
29,906
30,946
33,737
32,380
26,549
25,494
36,525
39,387
32,205
27,102
37,746
28,334
29,295
29,487
26,203
25,434
34,573
31,789
28,577
25,114
26,302
33,561
27,944
25,776
67,722
70,055
69,056
67,389
68,586
67,550
66,991
61,936
126,134
112,760
110,352
108,316
110,528
105,364
111,990
107,144
108,862
118,408
129,991
124,804
126,356
118,576
134,433
122,071
131,120
126,821
121,794
121,996
129,856
135,798
146,599
135,686
152,141
149,520
158,081
231,519
248,947
281,190
300,921
302,392
310,269
285,022
290,222
305,199
300,140
251,754
265,922
181,510
187,215
187,215
204,906
188,901
201,946
259,180
244,395
256,992
219,800
207,321
239,937
239,937207,321219,800256,992244,395259,180201,946188,901204,906187,215187,215181,510265,922251,754300,140305,199290,222285,022310,269302,392300,921281,190248,947231,519158,081149,520152,141135,686146,599135,798129,856121,996121,794126,821131,120122,071134,433118,576126,356124,804129,991118,408108,862107,144111,990105,364110,528108,316110,352112,760126,13461,93666,99167,55068,58667,38969,05670,05567,72225,77627,94433,56126,30225,11428,57731,78934,57325,43426,20329,48729,29528,33437,74627,10232,20539,38736,52525,49426,54932,38033,73730,94629,90637,76939,02232,35637,76937,56948,42250,26052,04255,64875,05869,24873,90073,40580,21879,81074,64766,73468,4008,9006,2006,70013,4008,7002,8003,70010,60014,60012,00012,8001,6001,8001,5002,0000
   > Total Current Liabilities 
0
1,600
1,100
1,400
1,300
12,500
11,700
14,500
10,500
3,700
2,700
6,000
10,800
4,000
3,600
6,300
48,500
46,778
56,307
60,737
62,657
56,721
56,698
54,568
61,877
43,547
40,880
43,217
42,956
32,983
34,849
28,120
35,106
34,849
27,095
28,224
30,338
29,137
23,459
23,516
34,578
37,438
32,205
27,102
37,746
20,834
22,295
22,911
20,127
19,858
28,004
25,720
22,075
16,954
19,183
26,468
21,351
18,665
27,935
30,279
30,676
29,495
30,695
40,256
40,590
35,978
66,684
53,569
50,222
48,274
50,753
44,167
50,855
46,067
48,391
53,370
62,189
55,840
56,159
49,318
62,615
46,356
56,516
53,433
46,948
47,173
51,454
57,812
70,191
71,187
88,375
86,827
97,122
118,943
137,091
146,831
144,361
157,970
164,388
153,729
173,914
125,349
101,888
103,653
122,264
90,065
79,231
79,231
195,696
83,099
37,673
35,414
40,254
38,778
38,872
40,523
35,290
35,29040,52338,87238,77840,25435,41437,67383,099195,69679,23179,23190,065122,264103,653101,888125,349173,914153,729164,388157,970144,361146,831137,091118,94397,12286,82788,37571,18770,19157,81251,45447,17346,94853,43356,51646,35662,61549,31856,15955,84062,18953,37048,39146,06750,85544,16750,75348,27450,22253,56966,68435,97840,59040,25630,69529,49530,67630,27927,93518,66521,35126,46819,18316,95422,07525,72028,00419,85820,12722,91122,29520,83437,74627,10232,20537,43834,57823,51623,45929,13730,33828,22427,09534,84935,10628,12034,84932,98342,95643,21740,88043,54761,87754,56856,69856,72162,65760,73756,30746,77848,5006,3003,6004,00010,8006,0002,7003,70010,50014,50011,70012,5001,3001,4001,1001,6000
       Short-term Debt 
0
200
200
200
200
300
300
0
300
0
100
200
100
100
100
100
7,900
2,919
14,824
13,193
18,096
20,423
22,803
20,581
12,913
12,904
7,863
12,291
10,389
10,305
7,924
9,355
14,938
7,924
6,822
7,375
5,985
1,414
548
139
7,468
155
2,018
45
39
34
28
156
82
86
5,127
4,094
3,093
0
593
0
593
84
4,521
4,329
4,329
4,329
4,330
4,330
4,330
4,330
18,678
14,512
14,535
11,047
9,933
7,011
6,989
6,017
6,055
6,980
12,550
16,891
8,353
7,650
13,527
8,546
11,548
7,930
6,440
4,940
7,940
15,440
14,940
16,940
31,940
43,940
46,940
53,791
61,791
83,992
77,203
74,123
93,377
84,028
91,974
45,027
32,889
36,054
44,988
44,945
45,625
45,625
0
51,725
1,455
0
0
1,758
9,039
4,914
4,889
4,8894,9149,0391,758001,45551,725045,62545,62544,94544,98836,05432,88945,02791,97484,02893,37774,12377,20383,99261,79153,79146,94043,94031,94016,94014,94015,4407,9404,9406,4407,93011,5488,54613,5277,6508,35316,89112,5506,9806,0556,0176,9897,0119,93311,04714,53514,51218,6784,3304,3304,3304,3304,3294,3294,3294,52184593059303,0934,0945,1278682156283439452,0181557,4681395481,4145,9857,3756,8227,92414,9389,3557,92410,30510,38912,2917,86312,90412,91320,58122,80320,42318,09613,19314,8242,9197,900100100100100200100030003003002002002002000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
32,000
42,000
39,900
40,599
46,704
146,953
0
488
773
773
773
773
773
773
7737737737737737734880146,95346,70440,59939,90042,00032,0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
300
300
500
300
1,400
1,100
600
1,300
800
900
1,400
1,200
1,400
1,300
1,700
24,300
23,520
21,741
19,374
18,629
22,012
17,190
17,241
18,470
14,534
15,363
11,512
10,362
13,280
11,725
13,748
11,861
11,725
14,960
16,096
16,659
11,223
18,306
18,532
19,005
15,194
23,968
22,898
13,151
10,364
13,880
16,725
14,148
11,624
18,991
18,438
16,420
10,134
12,430
19,997
15,809
11,361
14,354
18,254
19,050
15,145
16,747
18,531
19,219
14,669
23,420
27,257
26,369
27,931
32,256
29,380
34,761
29,734
32,115
37,379
39,516
28,312
35,009
31,946
36,921
25,091
30,904
31,613
25,914
24,764
25,868
26,951
37,483
35,240
34,668
27,027
31,719
46,431
53,973
46,162
47,145
63,660
51,647
50,722
60,892
56,323
47,569
46,355
59,098
20,014
15,802
15,802
27,971
16,366
14,762
15,691
19,023
22,144
16,334
18,010
14,967
14,96718,01016,33422,14419,02315,69114,76216,36627,97115,80215,80220,01459,09846,35547,56956,32360,89250,72251,64763,66047,14546,16253,97346,43131,71927,02734,66835,24037,48326,95125,86824,76425,91431,61330,90425,09136,92131,94635,00928,31239,51637,37932,11529,73434,76129,38032,25627,93126,36927,25723,42014,66919,21918,53116,74715,14519,05018,25414,35411,36115,80919,99712,43010,13416,42018,43818,99111,62414,14816,72513,88010,36413,15122,89823,96815,19419,00518,53218,30611,22316,65916,09614,96011,72511,86113,74811,72513,28010,36211,51215,36314,53418,47017,24117,19022,01218,62919,37421,74123,52024,3001,7001,3001,4001,2001,4009008001,3006001,1001,4003005003003000
       Other Current Liabilities 
0
1,100
600
700
800
10,800
10,300
13,900
9,200
2,900
1,800
4,400
9,500
2,500
2,200
4,500
16,300
20,339
19,742
25,905
16,189
13,726
16,250
14,124
14,720
13,597
15,935
16,199
6,801
8,757
3,428
4,143
4,697
3,428
4,506
3,989
4,501
4,854
4,048
3,853
4,487
4,498
5,335
3,426
24,116
6,402
4,896
3,332
3,759
4,029
273
427
395
2,818
3,323
3,769
3,532
3,176
5,669
4,992
5,056
6,055
6,961
16,245
16,686
16,635
24,424
11,524
9,072
8,365
7,316
7,148
7,823
8,642
8,967
7,952
9,912
9,535
11,954
8,868
11,786
11,567
13,232
13,184
14,120
17,040
17,336
15,137
16,095
17,101
19,142
13,798
16,746
17,435
20,828
16,189
19,402
19,569
19,012
18,502
20,404
22,404
20,300
20,028
17,018
23,492
16,885
16,885
731
14,205
18,745
0
0
10,821
11,386
16,945
14,497
14,49716,94511,38610,8210018,74514,20573116,88516,88523,49217,01820,02820,30022,40420,40418,50219,01219,56919,40216,18920,82817,43516,74613,79819,14217,10116,09515,13717,33617,04014,12013,18413,23211,56711,7868,86811,9549,5359,9127,9528,9678,6427,8237,1487,3168,3659,07211,52424,42416,63516,68616,2456,9616,0555,0564,9925,6693,1763,5323,7693,3232,8183954272734,0293,7593,3324,8966,40224,1163,4265,3354,4984,4873,8534,0484,8544,5013,9894,5063,4284,6974,1433,4288,7576,80116,19915,93513,59714,72014,12416,25013,72616,18925,90519,74220,33916,3004,5002,2002,5009,5004,4001,8002,9009,20013,90010,30010,8008007006001,1000
   > Long-term Liabilities 
0
400
400
400
300
300
300
100
100
800
100
2,700
2,600
2,700
2,600
2,600
19,900
19,956
18,340
19,073
17,561
16,684
17,202
14,680
13,181
12,101
11,162
7,043
5,466
4,586
2,920
4,236
3,916
2,920
2,811
2,722
3,399
3,243
3,090
1,978
1,947
1,949
26,870
23,676
7,500
7,500
7,000
6,576
6,076
5,576
6,569
6,069
6,502
8,160
7,119
7,093
6,593
7,111
39,787
39,776
38,380
37,894
37,891
27,294
26,401
25,958
59,450
59,191
60,130
60,042
59,775
61,197
61,135
61,077
60,471
65,038
67,802
68,964
70,197
69,258
71,818
75,715
74,604
73,388
74,846
74,823
78,402
77,986
76,408
64,499
63,766
62,693
60,959
112,576
111,856
134,359
156,560
144,422
145,881
131,293
116,308
179,850
198,252
148,101
143,658
91,445
107,984
107,984
9,210
105,802
164,273
223,766
204,141
218,214
180,928
166,798
160,336
160,336166,798180,928218,214204,141223,766164,273105,8029,210107,984107,98491,445143,658148,101198,252179,850116,308131,293145,881144,422156,560134,359111,856112,57660,95962,69363,76664,49976,40877,98678,40274,82374,84673,38874,60475,71571,81869,25870,19768,96467,80265,03860,47161,07761,13561,19759,77560,04260,13059,19159,45025,95826,40127,29437,89137,89438,38039,77639,7877,1116,5937,0937,1198,1606,5026,0696,5695,5766,0766,5767,0007,5007,50023,67626,8701,9491,9471,9783,0903,2433,3992,7222,8112,9203,9164,2362,9204,5865,4667,04311,16212,10113,18114,68017,20216,68417,56119,07318,34019,95619,9002,6002,6002,7002,6002,7001008001001003003003004004004000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
98,964
0
0
0
0
0
0
00000098,96400000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Warrants
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
38,510
0
0
0
0
0
0
00000038,51000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,431
1,157
422
490
211
0
3,487
0
0
0
0
0
0
0000003,48702114904221,1574,43100000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,100
1,900
0
1,700
1,500
0
0
0
0
0
0
0
0
000000001,5001,70001,9002,10000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
39,100
38,200
36,600
35,400
33,000
32,100
35,600
34,100
36,800
35,700
33,700
32,600
36,000
34,200
31,800
50,800
55,858
55,217
52,178
48,470
51,748
50,707
49,839
46,498
59,202
58,871
55,963
54,074
58,760
56,885
57,419
55,933
56,885
61,549
60,948
64,490
67,306
72,060
71,780
71,963
78,086
85,049
85,682
86,570
105,719
110,228
96,101
100,473
106,381
114,466
119,286
120,818
123,108
125,406
128,379
130,933
132,204
130,784
133,884
136,415
139,708
136,055
139,529
140,764
147,908
149,742
153,287
166,108
173,024
178,693
183,689
188,670
198,019
203,069
205,767
209,517
213,877
218,432
222,296
225,147
205,058
210,728
215,296
218,010
222,609
226,609
229,560
231,189
248,632
252,562
253,381
253,573
270,064
270,144
264,947
259,076
247,668
231,044
221,158
208,938
204,624
202,784
193,865
156,202
144,072
107,945
107,945
74,167
96,899
34,207
-13,560
1,421
-1,842
53,902
-3,938
15,449
15,449-3,93853,902-1,8421,421-13,56034,20796,89974,167107,945107,945144,072156,202193,865202,784204,624208,938221,158231,044247,668259,076264,947270,144270,064253,573253,381252,562248,632231,189229,560226,609222,609218,010215,296210,728205,058225,147222,296218,432213,877209,517205,767203,069198,019188,670183,689178,693173,024166,108153,287149,742147,908140,764139,529136,055139,708136,415133,884130,784132,204130,933128,379125,406123,108120,818119,286114,466106,381100,47396,101110,228105,71986,57085,68285,04978,08671,96371,78072,06067,30664,49060,94861,54956,88555,93357,41956,88558,76054,07455,96358,87159,20246,49849,83950,70751,74848,47052,17855,21755,85850,80031,80034,20036,00032,60033,70035,70036,80034,10035,60032,10033,00035,40036,60038,20039,1000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
77,200
77,300
89,900
92,156
92,177
92,555
92,786
92,882
93,186
93,191
93,371
100,650
100,801
100,802
110,098
110,110
110,564
110,240
110,337
110,564
116,841
116,932
121,282
121,805
121,950
122,191
123,411
126,019
126,288
126,907
127,687
129,474
129,560
130,455
130,846
131,368
112,974
114,955
26
26
26
26
26
26
27
27
27
27
27
27
26
26
26
26
26
26
26
26
27
27
27
27
27
27
27
27
27
27
27
27
27
27
27
28
28
28
28
28
28
29
29
29
29
29
29
29
29
29
29
29
29
29
30
30
30
30
30
0
0
30
30
31
37
37313030003030303030292929292929292929292929292828282828282727272727272727272727272727272626262626262626272727272727262626262626114,955112,974131,368130,846130,455129,560129,474127,687126,907126,288126,019123,411122,191121,950121,805121,282116,932116,841110,564110,337110,240110,564110,110110,098100,802100,801100,65093,37193,19193,18692,88292,78692,55592,17792,15689,90077,30077,20000000000000000
   Retained Earnings Total Equity000000-140,091-99,8990000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,200
0
-9,200
0
0
0
0
0
0
0
0
0
0
0
0
0
-58,465
-58,465
-58,465
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
94
0
92
94
-179
-331
-331
-212
-267
-301
-235
-202
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
327
430
432
329
568
915
1,148
1,059
1,135
540
64
-548
-421
-832
-2,808
-2,504
-2,103
-1,716
-1,358
-992
-816
-712
-586
-586
0
-286
-39,245
0
0
-39,245
-42,587
-43,441
0
0-43,441-42,587-39,24500-39,245-2860-586-586-712-816-992-1,358-1,716-2,103-2,504-2,808-832-421-548645401,1351,0591,148915568329432430327000000000000000000-202-235-301-267-212-331-331-1799492094000000000000000000000-58,465-58,465-58,4650000000000000-9,20009,20000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
174,036
174,268
0
0
0
0
0
0
000000174,268174,0360000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
67,800
67,900
67,900
68,000
70,200
70,300
75,500
75,600
75,600
75,900
76,500
77,000
76,900
-9,100
0
100
9,149
9,149
9,149
9,149
9,149
9,149
14,049
14,149
14,251
14,355
14,461
5,420
5,531
58,465
5,644
59,555
5,876
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
115,713
0
114,963
115,713
116,158
116,947
117,875
117,410
117,730
118,678
119,154
120,030
119,169
120,865
118,695
121,041
119,894
120,900
122,981
125,108
126,258
126,502
128,031
130,980
131,488
131,833
132,360
132,948
133,307
134,219
135,202
136,303
137,244
138,077
139,138
140,134
141,680
142,587
143,490
144,498
142,087
142,805
143,506
159,524
160,341
160,814
161,556
162,077
162,578
163,388
164,068
164,865
165,533
165,725
166,327
166,943
167,352
168,070
0
168,070
135,758
0
0
174,349
177,808
135,343
162,557
162,557135,343177,808174,34900135,758168,0700168,070167,352166,943166,327165,725165,533164,865164,068163,388162,578162,077161,556160,814160,341159,524143,506142,805142,087144,498143,490142,587141,680140,134139,138138,077137,244136,303135,202134,219133,307132,948132,360131,833131,488130,980128,031126,502126,258125,108122,981120,900119,894121,041118,695120,865119,169120,030119,154118,678117,730117,410117,875116,947116,158115,713114,9630115,71300000000000000005,87659,5555,64458,4655,5315,42014,46114,35514,25114,14914,0499,1499,1499,1499,1499,1499,1491000-9,10076,90077,00076,50075,90075,60075,60075,50070,30070,20068,00067,90067,90067,8000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-05-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue128,261
Cost of Revenue-86,411
Gross Profit41,85041,850
 
Operating Income (+$)
Gross Profit41,850
Operating Expense-49,038
Operating Income9,331-7,188
 
Operating Expense (+$)
Research Development8,575
Selling General Administrative43,013
Selling And Marketing Expenses5
Operating Expense49,03851,593
 
Net Interest Income (+$)
Interest Income0
Interest Expense-18,090
Other Finance Cost-0
Net Interest Income-18,090
 
Pretax Income (+$)
Operating Income9,331
Net Interest Income-18,090
Other Non-Operating Income Expenses0
Income Before Tax (EBT)9,5149,148
EBIT - interestExpense = 8,655
12,196
30,103
Interest Expense18,090
Earnings Before Interest and Taxes (EBIT)26,74527,604
Earnings Before Interest and Taxes (EBITDA)35,604
 
After tax Income (+$)
Income Before Tax9,514
Tax Provision-183
Net Income From Continuing Ops9,3319,331
Net Income12,013
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses135,449
Total Other Income/Expenses Net18318,090
 

Technical Analysis of Lifecore
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Lifecore. The general trend of Lifecore is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Lifecore's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Lifecore Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Lifecore Biomedical Inc..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 7.34 < 7.78 < 7.88.

The bearish price targets are: 4.76 > 4.33 > 3.6793.

Know someone who trades $LFCR? Share this with them.👇

Lifecore Biomedical Inc. Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Lifecore Biomedical Inc.. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Lifecore Biomedical Inc. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Lifecore Biomedical Inc.. The current macd is -0.0492427.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Lifecore price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Lifecore. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Lifecore price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Lifecore Biomedical Inc. Daily Moving Average Convergence/Divergence (MACD) ChartLifecore Biomedical Inc. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Lifecore Biomedical Inc.. The current adx is 17.97.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Lifecore shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Lifecore Biomedical Inc. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Lifecore Biomedical Inc.. The current sar is 6.58612558.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Lifecore Biomedical Inc. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Lifecore Biomedical Inc.. The current rsi is 52.80. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Lifecore Biomedical Inc. Daily Relative Strength Index (RSI) ChartLifecore Biomedical Inc. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Lifecore Biomedical Inc.. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Lifecore price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Lifecore Biomedical Inc. Daily Stochastic Oscillator ChartLifecore Biomedical Inc. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Lifecore Biomedical Inc.. The current cci is 12.58.

Lifecore Biomedical Inc. Daily Commodity Channel Index (CCI) ChartLifecore Biomedical Inc. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Lifecore Biomedical Inc.. The current cmo is 9.77774681.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Lifecore Biomedical Inc. Daily Chande Momentum Oscillator (CMO) ChartLifecore Biomedical Inc. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Lifecore Biomedical Inc.. The current willr is -36.24031008.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Lifecore is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Lifecore Biomedical Inc. Daily Williams %R ChartLifecore Biomedical Inc. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Lifecore Biomedical Inc..

Lifecore Biomedical Inc. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Lifecore Biomedical Inc.. The current atr is 0.48369209.

Lifecore Biomedical Inc. Daily Average True Range (ATR) ChartLifecore Biomedical Inc. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Lifecore Biomedical Inc.. The current obv is 11,557,153.

Lifecore Biomedical Inc. Daily On-Balance Volume (OBV) ChartLifecore Biomedical Inc. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Lifecore Biomedical Inc.. The current mfi is 64.35.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Lifecore Biomedical Inc. Daily Money Flow Index (MFI) ChartLifecore Biomedical Inc. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Lifecore Biomedical Inc..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-11-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-12-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-01-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-07BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-11BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-31STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-04-03RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-09ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.

6.3. Candlestick Patterns

Lifecore Biomedical Inc. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Lifecore Biomedical Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.798
Ma 20Greater thanMa 506.327
Ma 50Greater thanMa 1006.161
Ma 100Greater thanMa 2006.517
OpenGreater thanClose6.330
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Lifecore with someone you think should read this too:
  • Are you bullish or bearish on Lifecore? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Lifecore? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Lifecore Biomedical Inc.

I send you an email if I find something interesting about Lifecore Biomedical Inc..


Comments

How you think about this?

Leave a comment

Stay informed about Lifecore Biomedical Inc..

Receive notifications about Lifecore Biomedical Inc. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.